We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+27%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$577M
AUM Growth
+$117M
Cap. Flow
+$70.8M
Cap. Flow %
12.28%
Top 10 Hldgs %
35.5%
Holding
108
New
25
Increased
54
Reduced
16
Closed
13

Top Buys

Rank Stock Value
1
COR icon
Cencora
COR
+$14.9M
2
BDX icon
Becton Dickinson
BDX
+$11.1M
3
DHR icon
Danaher
DHR
+$10.9M
4
IMGN
Immunogen Inc
IMGN
+$9.93M
5
PODD icon
Insulet
PODD
+$8.9M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$10.2M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$10M
3
ELV icon
Elevance Health
ELV
+$9.95M
4
LLY icon
Eli Lilly
LLY
+$9.5M
5
IQV icon
IQVIA
IQV
+$9.08M

Sector Composition

Rank Sector Weight
1 Healthcare 98.94%
2 Industrials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRA icon
51
Natera
NTRA
$45.5B
$3.65M 0.63%
75,039
-50,004
-40% -$2.55M
EVH icon
52
Evolent Health
EVH
$471M
$3.62M 0.63%
119,492
-67,431
-36% -$2.18M
EWTX icon
53
Edgewise Therapeutics
EWTX
$4.73B
$3.52M 0.61%
454,247
+391,964
+629% +$3.31M
AKYA
54
DELISTED
Akoya BioSciences
AKYA
$3.48M 0.6%
471,000
+269,615
+134% +$1.8M
SAGE
55
DELISTED
Sage Therapeutics
SAGE
$3.29M 0.57%
70,033
+44,712
+177% +$2.22M
KRMD icon
56
KORU Medical Systems
KRMD
$152M
$3.1M 0.54%
899,063
+47,688
+6% +$187K
LXRX icon
57
Lexicon Pharmaceuticals
LXRX
$1.05B
$3.05M 0.53%
1,330,616
+655,288
+97% +$1.74M
IDYA icon
58
IDEAYA Biosciences
IDYA
$3.56B
$2.99M 0.52%
+127,339
New +$2.62M
ESPR
59
DELISTED
Esperion Therapeutics
ESPR
$2.96M 0.51%
2,132,309
+253,452
+13% +$354K
SWAV
60
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$2.88M 0.5%
10,076
-36,779
-78% -$10.2M
NAMS icon
61
NewAmsterdam Pharma
NAMS
$3.33B
$2.84M 0.49%
239,051
+124,051
+108% +$1.65M
BDTX icon
62
Black Diamond Therapeutics
BDTX
$121M
$2.52M 0.44%
+500,000
New +$1.02M
LBPH
63
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$2.51M 0.43%
+341,587
New +$2.59M
CDMO
64
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$2.49M 0.43%
177,900
-276,052
-61% -$4.71M
ARVN icon
65
Arvinas
ARVN
$580M
$2.48M 0.43%
+100,000
New +$2.57M
LYRA
66
DELISTED
LYRA THERAPEUTICS INC
LYRA
$2.47M 0.43%
+12,000
New +$1.67M
RCUS icon
67
Arcus Biosciences
RCUS
$3.69B
$2.44M 0.42%
120,049
+17,062
+17% +$325K
ACAD icon
68
Acadia Pharmaceuticals
ACAD
$5.07B
$2.4M 0.42%
+100,000
New +$2.22M
AXGN icon
69
Axogen
AXGN
$2.67B
$2.38M 0.41%
260,858
+37,075
+17% +$346K
TVTX icon
70
Travere Therapeutics
TVTX
$5.86B
$2.25M 0.39%
146,323
+4,436
+3% +$80.7K
IRON icon
71
Disc Medicine
IRON
$3.09B
$2.22M 0.38%
+50,000
New +$1.77M
LQDA icon
72
Liquidia Corp
LQDA
$7.01B
$2.21M 0.38%
281,134
-45,831
-14% -$356K
COGT icon
73
Cogent Biosciences
COGT
$6.76B
$2.2M 0.38%
185,782
+3,886
+2% +$44.6K
CVRX icon
74
CVRx
CVRX
$72.7M
$2.17M 0.38%
+140,763
New +$1.72M
CSTL icon
75
Castle Biosciences
CSTL
$960M
$2.03M 0.35%
+148,002
New +$3M
1 2
3
4 5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Parkman Healthcare Partners held 108 positions worth $577M, up 25% from $460M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parkman Healthcare Partners deployed $70.8M of net new capital in Q2 2023, opening 25 new positions and adding to 54 existing holdings. Its largest new stake was Cencora: 86,250 shares worth $16.6M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Shockwave Medical, Inc. Common Stock, an estimated $10.2M trimmed.

  • Parkman Healthcare Partners's largest Q2 2023 buy was Cencora: 86,250 shares worth $16.6M.
  • Parkman Healthcare Partners added most to Becton Dickinson in Q2 2023, an estimated $11.1M increase.
  • Parkman Healthcare Partners's biggest Q2 2023 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $10.2M.
  • Parkman Healthcare Partners fully exited Elevance Health in Q2 2023, selling an estimated $9.95M.
  • Parkman Healthcare Partners's ten largest holdings make up 35% of its $577M portfolio in Q2 2023.
  • Parkman Healthcare Partners opened 25 new positions and closed 13 in Q2 2023.
  • Parkman Healthcare Partners's portfolio value rose 25% quarter-over-quarter to $577M.

Based on Parkman Healthcare Partners's 13F filing for Q2 2023, filed 11 Aug 2023.